Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
534.00
-19.15 (-3.46%)
Nov 3, 2026, 2:03 PM EST - Market open

Vertex Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
3,4413,3342,9873,1903,0762,9442,7602,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,073
Other Revenue
-----20.710-------------
Revenue
3,4413,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,073
Revenue Growth (YoY)
11.85%12.45%7.82%9.55%10.98%12.06%2.96%15.66%11.61%6.11%13.30%9.34%6.39%13.52%13.22%11.10%17.65%22.46%21.64%27.32%
Cost of Revenue
526.11,4831,3541,4401,3931,3861,3431,4221,2691,3391,1321,1931,1291,0941,010977.4934.4848.9846.9815.2
Gross Profit
2,9151,8511,6331,7501,6841,5791,4281,4901,5031,3071,5591,3251,3551,3991,3651,3251,4001,3471,2511,257
Selling, General & Admin
844.1582.2493.7487445.1424.6396.4377.6371.8372.2342.7369.1263.8262.6241.1267.4246.8215.3215.2255.2
Research & Development
1,321-------------------
Operating Expenses
2,165582.2493.7487445.1424.6396.4377.6371.8372.2342.7369.1263.8262.6241.1267.4246.8215.3215.2255.2
Operating Income
7501,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,002
Interest Expense
-36---3.3-3.3---2.8-7.5-9.9-10.4-10.6-10.9-11.2-11.4-11.6-13.7-14.6-14.9-15.1
Interest & Investment Income
118.4120.6114.8121.9125.7118.7117.9128.2132.2156.5181.2179.5167.9144.7122.68646.210.81.61.2
Currency Exchange Gain (Loss)
--13.42.913.5-22.9-3.1-1.2-11.60.1-13.4-2.4-6.8-220.63.623.8-22.1-8.4-8.4-4.5
Other Non Operating Income (Expenses)
-11.946.2-6.7-14.314.69.9-1.4-6.4-19.83-26.1-2.612.3-8.2-8.7-48.939.314.511.2-0.5
EBT Excluding Unusual Items
820.51,4221,2501,3811,3531,2801,1461,2201,2371,0711,3591,1161,2381,2621,2301,1071,2031,1341,025983.3
Gain (Loss) on Sale of Investments
--8.53.87.3-1.56.4-153.12.8-12.7-2.7-0.4-6.29.26.4-6--84.2-75.612.1
Asset Writedown
-------379-----------13--
Other Unusual Items
3.5-0.4-0.2-0.91.9-0.9-2.21.2-0.3-0.50.150.3-1.20.61.9-1.82.649.27.52
Pretax Income
783.41,3921,2531,3311,2991,283730.41,1371,224-3,3911,2791,1481,1791,162891.51,0771,1761,024954.8870.9
Income Tax Expense
129.8292221.5139.9215.9250.184.1223.5178.7202.4179.5178.8143.9245.8191.7257.9245.9213.9192.7100.8
Earnings From Continuing Operations
653.61,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1
Net Income
653.61,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1
Net Income to Common
653.61,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1
Net Income Growth (YoY)
-39.64%6.48%59.59%30.46%3.59%--41.22%-5.76%0.98%-57.13%18.30%11.26%12.98%-8.18%6.34%9.23%1109.70%16.69%27.45%
Shares Outstanding (Basic)
254254254254256257257258258258258258258258257257257256255255
Shares Outstanding (Diluted)
255255256256258259260261261258261261261260260260260259258257
Shares Change (YoY)
-0.93%-1.43%-1.23%-1.69%-1.30%0.31%-0.61%-0.15%0.15%-0.88%0.31%0.23%0.42%0.66%0.93%1.28%-0.08%-0.88%-1.53%-2.32%
EPS (Basic)
2.584.344.064.694.244.022.523.554.05-13.924.263.764.013.552.723.193.633.172.993.02
EPS (Diluted)
2.564.314.024.654.203.992.493.504.01-13.924.213.713.973.522.693.143.593.132.962.99
EPS Growth (YoY)
-39.05%8.02%61.45%32.88%4.74%--40.86%-5.64%1.01%-56.51%18.08%10.59%12.46%-9.12%5.02%9.45%1109.96%18.88%30.38%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-1,0131,295348.61,140927.4778.24921,302-3,8231,238176.51,2281,075857.81,045901.31,087892.6933.2
Free Cash Flow Per Share
-3.975.051.364.423.583.001.894.99-14.814.740.684.714.133.294.013.474.203.463.63
Gross Margin
84.71%55.52%54.66%54.87%54.74%53.25%51.53%51.16%54.24%49.41%57.94%52.63%54.55%56.11%57.49%57.55%59.97%61.35%59.62%60.67%
Operating Margin
21.80%38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%
Profit Margin
19.00%32.99%34.53%37.34%35.20%34.84%23.33%31.35%37.71%-135.83%40.87%38.48%41.69%36.73%29.47%35.56%39.86%36.91%36.33%37.16%
Free Cash Flow Margin
-30.39%43.35%10.93%37.04%31.28%28.09%16.90%46.98%-144.49%46.02%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.55%45.03%
EBITDA
806.51,3251,1951,2881,2931,2061,0801,1341,185988.91,2701,0031,1331,1781,1631,0961,1901,1691,0711,036
EBITDA Margin
23.44%39.75%40.00%40.37%42.02%40.67%38.97%38.93%42.74%37.38%47.19%39.85%45.63%47.24%48.97%47.61%50.97%53.24%51.08%49.99%
D&A For EBITDA
56.556.555.924.55451.748.421.353.25453.547.242.141.438.838.436.737.335.933.8
EBIT
7501,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,002
EBIT Margin
21.80%38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%
Effective Tax Rate
16.57%20.98%17.68%10.51%16.62%19.49%11.51%19.67%14.60%-14.03%15.58%12.20%21.16%21.50%23.95%20.90%20.88%20.18%11.57%
Revenue as Reported
3,4413,3342,9873,1903,0762,9652,7702,9122,7722,6462,691----8,931---2,073
SEC Filings: 10-K · 10-Q